Institutional investors holding Lucid Group, Inc. securities between February 25 and April 13, 2026, face an approaching July 28 deadline to seek lead plaintiff status. The pending class action centers on allegations that the automaker concealed significant supplier quality defects and manufacturing disruptions that led to a sharp stock decline.
Tampa-based contract lifecycle management firm IntelAgree has achieved co-sell readiness with Microsoft, enabling enterprise clients to purchase its AI-powered platform directly through the Microsoft Marketplace. The integration allows businesses to apply their existing Azure Consumption Commitments toward the software, effectively streamlining procurement within their established cloud budgets.
Verra Mobility Corporation investors are seeking damages through a pending class action lawsuit following a 71% stock plunge triggered by the abrupt termination of a major Avis Budget Group contract. The litigation centers on claims that the company misled shareholders regarding the stability of its rental car revenue streams.
A class action lawsuit has been filed against GeneDx Holdings Corp. after a May 2026 earnings disclosure triggered a 49% stock drop. The litigation alleges that the company artificially inflated its value by concealing material problems regarding the Fabric Genomics acquisition and declining reimbursement rates for its testing services.
Investors who purchased Intuit Inc. securities between August 22, 2025, and May 20, 2026, have until September 8, 2026, to seek lead plaintiff status in a pending securities class action. The lawsuit alleges the company concealed critical competitive and pricing pressures within its core TurboTax business.
Investors who purchased Peabody Energy Corporation stock between October 2024 and May 2026 are facing a class action lawsuit following allegations that the company misled shareholders regarding operational readiness at its Centurion mine and inflated key metallurgical coal production guidance.
Investors have initiated a class action lawsuit against Insulet Corporation, alleging the medical device manufacturer misled shareholders by touting robust quality controls while its Acton, Massachusetts facility produced roughly seven million flawed insulin pods. The litigation centers on disclosures made between February 2025 and May 2026.
A 50.55% collapse in Grail, Inc. shares on February 20, 2026, has triggered a securities class action lawsuit. The legal action centers on the company’s failure to meet primary endpoints in its NHS-Galleri trial, a development that wiped out $51.32 per share and shattered investor confidence in the firm's clinical projections.
Investors who incurred losses in Helen of Troy Limited between April 24, 2024, and October 8, 2025, have until August 3, 2026, to apply for lead plaintiff status. The ongoing litigation centers on allegations that management misled shareholders regarding the efficacy of the company’s restructuring initiative, Project Pegasus.
BitGo Holdings faces a securities class action lawsuit alleging that management’s repeated assurances of business resilience masked significant financial risks. Investors who purchased shares between January 22, 2025, and May 13, 2026, are now seeking recovery after the company’s stock price plummeted following disclosures of a $14.8 million net loss.
Investors who suffered losses in Badger Meter, Inc. have until August 3, 2026, to file for lead plaintiff status. The legal action follows a 24% single-day stock collapse on April 17, 2026, triggered by disclosures that revenue and demand metrics fell significantly short of previous management projections.
Investors have launched a class action lawsuit against ADMA Biologics, claiming the company masked a decline in ASCENIV sales through channel stuffing. The litigation targets public revenue projections made between August 2024 and March 2026, challenging the company’s assertion of robust 20% growth against evidence of a shrinking market share.
A federal securities class action is centering on former Hub Group CFO Kevin Beth, who allegedly oversaw a $77 million understatement of transportation costs. With the lead plaintiff deadline set for August 28, 2026, investors are scrutinizing financial certifications signed during a period of significant stock volatility.
Institutional investors who held AeroVironment shares between June 2025 and March 2026 are weighing lead plaintiff options following a collapse in stock value. The litigation centers on alleged misrepresentations regarding the company’s $1.7 billion SCAR contract, which culminated in a total contract termination and significant financial impairment.
Investors who purchased Regeneron Pharmaceuticals shares between August 1, 2025, and May 15, 2026, face a September 14, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit regarding the company's handling of its Phase III Fianlimab-Libtayo clinical trial.
Investors who purchased Black Rock Coffee Bar securities between September 12, 2025, and May 12, 2026, face an August 17, 2026, deadline to serve as lead plaintiff in a class action lawsuit alleging the company misled shareholders regarding the impact of its rapid store expansion.
Investors who acquired Intuit Inc. securities between August 22, 2025, and May 20, 2026, are now eligible to participate in a class action lawsuit. The litigation alleges that the company misled shareholders regarding its competitive standing and the sustainability of its growth projections during that period.
More than 45,000 seniors in Maryland struggle with food insecurity, a crisis driven by fixed incomes and limited access to healthy options. To address this, Operation Pathways has received a 2026 Thome Aging Well Grant to implement a targeted food access program at two Baltimore residential properties.
Retail and consumer companies often struggle with specific, profit-draining challenges that neither a full-time executive hire nor a traditional consultant can effectively solve. The Convened, a new collective from Eunity Partners, intends to bridge this gap by embedding seasoned operators directly into firms to handle high-stakes execution until outcomes stabilize.
A first-in-human clinical study published in Nature reveals that C-CAR031, an armored CAR-T cell therapy, achieved tumor regression in nearly 90% of patients with heavily pretreated advanced hepatocellular carcinoma. The findings validate a novel approach to overcoming the immunosuppressive barriers typically found in solid tumors.
As experienced professionals retire, Pennsylvania American Water is attempting to secure the future of the state’s utility infrastructure by launching aggressive recruitment and mentorship initiatives. The company is betting on early-career exposure to bridge the widening gap between aging expertise and the next generation of essential water workers.
Before a dental implant can mimic the function of a natural tooth, it requires a stable environment: healthy gums and sufficient bone density. Dr. Danika Crabtree, a periodontist based in Warwick, Rhode Island, warns that skipping the foundational prep work often leads to implant instability or failure.
Two YMX Logistics executives, CEO Matt Yearling and Vice President Adam Buttgenbach, have earned spots as finalists for the 2026 Truck Fleet Innovator award. The recognition, presented by Heavy Duty Trucking, highlights their contributions to modernizing yard operations through electrification, artificial intelligence, and autonomous technology deployment.
Greenville-based FerebeeLane has secured the Ad Age 2026 Southeast Small Agency of the Year title, marking the first time a firm from the South Carolina city has claimed the honor. The award highlights the independent agency’s distinct approach to luxury brand strategy and its rapid financial expansion over the past year.
Off the coast of Keyport, Washington, the U.S. Navy turned its attention to the murky challenges of modern littoral defense during the 2026 Lanternfish exercise. There, Ultra Maritime deployed its Sea Spear sonar system to tackle a growing tactical headache: the detection and classification of advanced unmanned underwater vehicles.
Mark Talens, a veteran executive with over 25 years of experience in pharmaceutical supply chains and AI strategy, has joined Indianapolis-based PAXAFE as Chief Commercial Officer. He is tasked with scaling global operations and partnerships to meet surging demand for the company’s AI-powered cold chain decision intelligence platform.
The Association of Black Cardiologists will convene at Cipriani Wall Street on October 3, 2026, for its 16th Annual Spirit of the Heart Awards. The fundraiser aims to secure critical resources for medical scholarships and fellowships, highlighting the organization's ongoing mission to eliminate disparities in cardiovascular care.
Andy Calvert of Washington, D.C., secured the 2026 National Visionary of the Year title after raising $624,548 for Blood Cancer United. The campaign, which challenges volunteers to lead 10-week fundraising initiatives, honored top performers across the country who turned personal experiences with blood cancer into substantial support for research and advocacy.
Halloween has officially outgrown the calendar, transforming from a single night of trick-or-treating into a sprawling, multi-month retail phenomenon. Driven by the rise of Summerween and shifting consumer habits among younger generations, over half of U.S. adults now view the holiday as an extended seasonal experience rather than a singular date.
Infosys reported $5.08 billion in revenue for the first quarter of fiscal 2027, marking a 2.4% year-over-year increase in constant currency. The company’s strategic pivot toward artificial intelligence is yielding tangible results, with AI-related work now accounting for 8.2% of total revenue during the period ending June 30.
